Diagnostics: The New Gatekeepers to Drugs

After Trophos’ recent ALS drug failure, the importance of diagnostics was made clear. Trophos’ drug failed in a Phase III clinical trial and one of the suspected reasons for the failure was the advanced stage of disease in many of the participants. This recent New York Times story discusses a growing trend towards the co-development of “companion diagnostics” together with new drugs; the next phase of personalized medicine.

Click here to read more.

Share this:
Facebooktwittergoogle_plusmailFacebooktwittergoogle_plusmail